May 2004
Investment Dealers' Digest;5/17/2004, Vol. 70 Issue 20, p35
Trade Publication
Presents tables indicating the aftermarket performance of initial public offerings (IPO) and stocks in the United States. Offer price; Price on May 12, 2004; Percent change; Book manager; CrossTex Energy; Jed Oil; Marchex; Eyetech Pharmaceuticals; Kinetic Concepts; Daystar Technologies; Startek Holdings; TRW Automotive Holdings; Semiconductor Manufacturing; TOM Online; Nuvasive; Atlas America; InfraSource Services.


Related Articles

  • IPOs IN THE U.S.  // Investment Dealers' Digest;1/12/2004, Vol. 70 Issue 2, p60 

    Provides information on initial public offerings in the U.S. Eyetech Pharmaceuticals Inc.; TRW Automotive Inc.; Kinetic Concepts Inc.

  • IPOs IN THE U.S.  // Investment Dealers' Digest;1/19/2004, Vol. 70 Issue 3, p64 

    Presents data on initial public offering (IPO) deals in the United States, for the week ending January 26, 2004. Eyetech Pharmaceuticals; TRW Automotive; K-Sea Transportation; Lipman Electronic Engineering.

  • AFTERMARKET PERFORMANCE.  // Investment Dealers' Digest;2/23/2004, Vol. 70 Issue 8, p35 

    Presents charts and graphs of the stock price performance of companies which went public in early 2004. Rate of return as of February 18, 2004; Stock price graphs of CrossTex Energy and GTx; Investment banks involved in initial public offerings.

  • IPOs in the U.S.  // Investment Dealers' Digest;12/16/2002, Vol. 68 Issue 48, p18 

    Presents data related to initial public offerings market in the U.S. as of December 2002. Amount of business conducted by Wooster, Ohio based bank Ohio Legacy; Number of shares offered by Dallas, Texas based oil and gas exploration production company Crosstex Energy LP.

  • On Eyetech Secondary Where's CSFB? Santini, Laura // Investment Dealers' Digest;5/31/2004, Vol. 70 Issue 22, p11 

    Reports on the absence of Credit Suisse First Boston (CSFB) during the secondary stock offerings of its former client, Eyetech Pharmaceuticals Inc. in the U.S. Worries of some bankers whether staffing problems of CSFB led the company's failure to join the stock offering; Observation of people...

  • TRW would be OK on its own. Bolduc, Douglas A. // Automotive News Europe;5/14/2007, Vol. 12 Issue 10, p1 

    The article reports that TRW Automotive is not concerned if its primary shareholder Blackstone exited and it became 100% publicly owned according to TRW executive vice president and chief operating officer (COO) Steve Lunn. Europe accounted for 57% of the company's $13.1 billion in sales in...

  • TRW stock nosedives after IPO; Big Three pressures hurt profits. Sherefkin, Robert // Crain's Detroit Business;9/13/2004, Vol. 20 Issue 37, p4 

    This article reports that TRW Automotive Inc.'s stock price is down nearly 30 percent since its initial public offering in February. The company ranks first or second in market share in North America and Europe for key areas such as antilock brake systems, steering systems, engine valves,...

  • Clinical Trial Status Differentiates Biotechs. Santini, Laura // Investment Dealers' Digest;2/23/2004, Vol. 70 Issue 8, p11 

    Discusses how the status of clinical trials affects the share price of biotech companies after going public. Success of the initial public offering (IPO) of Eyetech Pharmaceuticals Inc.; Contrast with the IPO of GTx Inc.; Rethinking among investment bankers in the wake of contrasting results.

  • Aftermarket performance.  // Investment Dealers' Digest;02/15/99, Vol. 65 Issue 7, p14 

    Presents information on the aftermarket in the United States as of February 15, 1999. Initial public offering performance in the last 60 days; Performance of recent initial public offerings; Performance of recent stock offerings.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics